Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. (VNDA) — Form 10-Q: Quarterly report

10-QVNDAFiled Oct 29, 2026, 4:00 AM ET· Period Sep 30, 2026

About this filing

Vanda Pharmaceuticals Inc. (VNDA) filed Form 10-Q (quarterly report) with the SEC on Oct 29, 2026. A 10-Q is the company’s quarterly financial report.

View original filing on SEC.gov

Key facts

Document: 10-Q

More VNDA filings

SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Nov 13, 2026
4
Insider transaction
Filed Nov 5, 2026
8-K
Current report
Filed Oct 28, 2026
SC 13G
Ownership over 5% (passive)
Filed Oct 27, 2026
SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Oct 9, 2026
SC 13G
Ownership over 5% (passive)
Filed Aug 19, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.